Using antibodies against immune deficiency
Early, intensive therapy with a biotechnologically produced medication can provide significantly faster pain relief for patients with rheumatic joint inflammation. Damage to joints can also be reduced when the medication is applied right at the beginning of the illness. A nationwide study sponsored by the Federal Ministry of Education and Research and conducted by Prof. Gerd-Rüdiger Burmester, director of the Medical Department, Division of Rheumatology and Clinical Immunology at Charité – Universitätsmedizin Berlin, came to this conclusion. Findings are published in the Annals of the Rheumatic Diseases.
In the study, the standard preparation of methotrexate was tested in comparison with a combined therapy of methotrexate and the biological agent (or biologic) adalimumab in treating rheumatoid arthritis. Biologics are a particular group of medication produced from living cells using methods of molecular biology. The medication exclusively targets particular messenger substances in the immune system. It clings to the body's inflammatory substances and renders them harmless. Pain, swelling and the progress of inflammation are thus prevented.
The medication tested by Prof. Burmester's work group is called adalimumab and was approved ten years ago. It is one of the most frequently prescribed biologics worldwide. It is prescribed when standard therapies are inadequate or when side effects develop. The Charité study examined how the medication affects patients with rheumatoid joint inflammation when the therapy is started immediately following diagnosis and not only when other therapies do not take effect. Study participants had rheumatoid arthritis in the early stages, however, were considerably limited in their daily activities as a result of the symptoms. Half of the patients were given the combination therapy for six months and the other half serving as the comparison group was given the standard medication and a placebo. All test participants were then given methotrexate for another six months. Though both groups had comparable symptoms at the end of study, the group that was given the biologic experienced significantly faster pain relief. Furthermore, x-rays showed less bone damage in those patients compared to the placebo group. Prof. Burmester is confident: "We were able to show that early, intensive therapy with this biologic helps patients maintain their quality of life and prevent bone damage."
More information: Detert J, et al. Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study. Ann Rheum Dis. 2012 Jul 10. doi:10.1136/annrheumdis-2012-201612. http://ard.bmj.com/content/early/2012/06/26/annrheumdis-2012-201612.full
Journal reference: Annals of the Rheumatic Diseases
Provided by Charité - Universitätsmedizin Berlin
- Head-to-head study in RA shows that abatacept has comparable efficacy to adalimumab Jun 07, 2012 | not rated yet | 0
- Anakinra for rheumatoid arthritis: A modest benefit with some risk Jan 21, 2009 | not rated yet | 0
- Combining medications often best strategy to battle rheumatoid arthritis Nov 19, 2007 | not rated yet | 0
- DMARDs, glucocorticoids and biologics equally effective for rheumatoid arthritis Sep 28, 2010 | not rated yet | 0
- New guidelines for treating rheumatoid arthritis Jul 22, 2008 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Change in momentum when a body is thrown up and falls back down.
2 hours ago Say, a body of mass 'm' is thrown at a certain angle with the vertical with certain initial velocity 'u'. The initial momentum of this object is mu....
change in speed and wavelength of light while travelling from one med
2 hours ago what is the mechanism by which light changes its speed and wavelength while travelling from one medium to other. I know it is c/n or lamda/n and know...
Calculus of Variation - Classical Mechanics
5 hours ago I'm reading Classical Mechanics (Taylor), and the 6th chapter is a basic introduction to calculus of variations. I'm super confused :confused: ...
Frictional Force Equation Doesn't Make Sense
5 hours ago Frictional Force is mathematically defined as: Ff = μ*m*g*cos(θ) , where μ is the coefficient of friction, m is the mass of the object, g is...
Calculating Steam Pressure in Closed Container
10 hours ago I am trying to calculate the volume of liquid water i need to place in a sealed container in order to obtain 10 psi of steam pressure in that closed...
Learning curve of Electromagnetism?
15 hours ago I'm taking a first year physics course and have been having a little trouble with the basics of newtons laws and forces and whatnot, though nothing...
- More from Physics Forums - Classical Physics
More news stories
(HealthDay)—Compared to clinical diagnosis of synovitis, ultrasound-detected synovitis provides either improved sensitivity or specificity when used with the American College of Rheumatology/European League ...
Arthritis & Rheumatism May 15, 2013 | not rated yet | 0
(HealthDay)—A genome-wide linkage scan has identified the chromosome 17p11.2-q11.2 region as the susceptibility locus for fibromyalgia, according to research published in the April issue of Arthritis & ...
Arthritis & Rheumatism May 11, 2013 | not rated yet | 0
Scientists have discovered that fat cells in the knee secrete a protein linked to arthritis, a finding that paves the way for new gene therapies that could offer relief and mobility to millions worldwide.
Arthritis & Rheumatism May 08, 2013 | 5 / 5 (5) | 0 |
Researchers from the Royal College of Surgeons in Ireland (RCSI) have discovered that a new treatment for the inflammatory condition, Systemic Lupus Erythmstosus (SLE) could potentially benefit Irish patients who suffer from ...
Arthritis & Rheumatism May 07, 2013 | not rated yet | 0
A team of researchers led by a Boston University Biomedical Engineer has developed a new joint lubricant that could bring longer lasting relief to millions of osteoarthritis sufferers. The new synthetic polymer supplements ...
Arthritis & Rheumatism May 02, 2013 | 4 / 5 (1) | 0
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...
4 hours ago | not rated yet | 0 |
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
4 hours ago | 4.5 / 5 (2) | 0 |
Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.
4 hours ago | not rated yet | 0
The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...
4 hours ago | not rated yet | 0
There are significant cost and risk factors associated with two procedures commonly used to diagnose or treat gastrointestinal problems, according to research presented at Digestive Disease Week (DDW).
4 hours ago | not rated yet | 0
An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).
19 hours ago | not rated yet | 0 |